CTOs on the Move

Symbiomix Therapeutics

www.symbiomix.com

 
Symbiomix (sim-bye-OH-mix) is a late-stage, privately held biopharmaceutical company developing innovative medicines for serious women`s health infections that have been long neglected and are in need of new therapeutic options. Symbiomix was founded in 2012 by a team of experienced industry professionals and entrepreneurs and is backed by three of the world`s leading healthcare venture capital firms, OrbiMed, Fidelity Biosciences and HBM Partners. The Company`s lead product is SYM-1219, a novel drug candidate containing secnidazole, which is a next generation 5-nitroimidazole antibiotic. Symbiomix is based in New Jersey, with additional offices in Maryland and Connecticut.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.symbiomix.com
  • 105 Lock Street Suite 409
    Newark, NJ USA 07103-3576
  • Phone: 609.722.7250

Executives

Name Title Contact Details

Funding

Symbiomix Therapeutics raised $41M on 05/06/2015

Similar Companies

DTx Inc.

DTx Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Melbourne, FL. To find more information about DTx Inc., please visit www.dtx.com.

Primewest Health System

Primewest Health System is a Alexandria, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Heartbeat Experts

Heartbeat Experts is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

M3 USA Corporation

M3 USA Corporation is a Park Ridge, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Medical Transactions

Medical Transactions is a Eden Prairie, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.